} ?>
(Yicai Global) May 27 -- Medical testing system provider Wuhan Thalys Medical Technology has struck a cooperation agreement with financial technology giant Ant Financial Services Group to apply blockchain technology to its medical service system.
Thalys shares [SHA:603716] hit the 10 percent daily limit up bourse rules impose at today's market opening to close at CNY18.81 (USD2.7) per share.
Thalys' collaboration with Ant Financial, which is the payment arm of China's tech titan Alibaba Group Holding, encompasses identity authentication, payment and data capture, Thalys announced yesterday, but without detailing financial aspects of the deal. Thalys, which is based in Wuhan, the capital of China's eastern Hubei province, may not cooperate with other companies on blockchain-related businesses during their cooperation without Hangzhou-based Ant Financial's approval, per the announcement.
Thalys provides medical information platforms that offer varied technical services to hospitals and testing institutes serving them, public information shows.
The cooperation will not affect Thalys' operating independence, as Thalys' main businesses does not rely on Ant Financial, the announcement stressed.
Editor: Ben Armour